ID
25195
Descripción
Phase A - Year 1 - Telephone contact 8 - GSK Study: Evaluation of safety and efficacy of VarilrixTM and of Combined Measles-Mumps-Rubella-Varicella Vaccine NCT00226499 Study ID: 100388 Clinical Study ID: 100388 Study Title: Study in Healthy Children (<2 Years) to Evaluate the Safety and Efficacy of GSK Biologicals' Live Attenuated Varicella Vaccine (VarilrixTM) and of GSK Biologicals' Combined Measles-Mumps-Rubella-Varicella Vaccine Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00226499 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: Varicella Vaccine Trade Name: BIO OKAH; Varilrix Study Indication: Varicella
Palabras clave
Versiones (1)
- 28/8/17 28/8/17 -
Titular de derechos de autor
glaxoSmithKline
Subido en
28 de agosto de 2017
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY-NC 3.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
Phase A - Year 1 - Telephone contact 8 - GSK Study: Evaluation of safety and efficacy of VarilrixTM and of Combined Measles-Mumps-Rubella-Varicella Vaccine NCT00226499
Phase A - Year 1 - Telephone contact 8 - GSK Study: Evaluation of safety and efficacy of VarilrixTM and of Combined Measles-Mumps-Rubella-Varicella Vaccine NCT00226499
Descripción
Household exposure
Alias
- UMLS CUI-1
- C0332157
- UMLS CUI-2
- C0020052
Descripción
Exposure in household to varicella/zoster
Tipo de datos
boolean
Alias
- UMLS CUI [1,1]
- C0008049
- UMLS CUI [1,2]
- C0332157
- UMLS CUI [1,3]
- C0020052
- UMLS CUI [2,1]
- C0740380
- UMLS CUI [2,2]
- C0332157
- UMLS CUI [2,3]
- C0020052
Descripción
Household exposure number
Alias
- UMLS CUI-1
- C0332157
- UMLS CUI-2
- C0020052
- UMLS CUI-3
- C0449788
Descripción
Household Exposure No
Tipo de datos
integer
Alias
- UMLS CUI [1,1]
- C0332157
- UMLS CUI [1,2]
- C0020052
- UMLS CUI [1,3]
- C0449788
Descripción
Date of onset exposure
Tipo de datos
date
Alias
- UMLS CUI [1,1]
- C0574845
- UMLS CUI [1,2]
- C0332157
Descripción
Type of exposure
Tipo de datos
integer
Alias
- UMLS CUI [1]
- C0332157
Descripción
Varicella or zoster
Alias
- UMLS CUI-1
- C0008049
- UMLS CUI-3
- C0740380
Descripción
if 'yes', please complete the Varicella or Zoster Case section.
Tipo de datos
boolean
Alias
- UMLS CUI [1,1]
- C0037088
- UMLS CUI [1,2]
- C0740380
- UMLS CUI [2,1]
- C0037088
- UMLS CUI [2,2]
- C0008049
Descripción
Number of episodes of varicella/zoster signs and symptoms
Tipo de datos
integer
Alias
- UMLS CUI [1,1]
- C0037088
- UMLS CUI [1,2]
- C0740380
- UMLS CUI [2,1]
- C0037088
- UMLS CUI [2,2]
- C0008049
Descripción
Serious adverse event
Alias
- UMLS CUI-1
- C1519255
Similar models
Phase A - Year 1 - Telephone contact 8 - GSK Study: Evaluation of safety and efficacy of VarilrixTM and of Combined Measles-Mumps-Rubella-Varicella Vaccine NCT00226499
C0681850 (UMLS CUI [1,2])
C0332157 (UMLS CUI [1,2])
C0020052 (UMLS CUI [1,3])
C0740380 (UMLS CUI [2,1])
C0332157 (UMLS CUI [2,2])
C0020052 (UMLS CUI [2,3])
C0020052 (UMLS CUI-2)
C0449788 (UMLS CUI-3)
C0020052 (UMLS CUI [1,2])
C0449788 (UMLS CUI [1,3])
C0332157 (UMLS CUI [1,2])
C0740380 (UMLS CUI [1,2])
C0037088 (UMLS CUI [2,1])
C0008049 (UMLS CUI [2,2])
C0740380 (UMLS CUI [1,2])
C0037088 (UMLS CUI [2,1])
C0008049 (UMLS CUI [2,2])
Sin comentarios